Literature DB >> 2982093

Safety of the hepatitis B vaccine.

C E Stevens, P E Taylor, P Rubinstein, R C Ting, A J Bodner, M G Sarngadharan, R C Gallo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2982093     DOI： 10.1056/NEJM198502073120613

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Preventing hepatitis B in health care workers.

Authors:  S C Pappas; M M Fisher
Journal:  Can Fam Physician       Date:  1985-10       Impact factor: 3.275

2.  Time for action on hepatitis B immunisation.

Authors:  R G Finch
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-24

3.  Absence of risk of human immunodeficiency virus (HIV) infection in recipients of hepatitis B vaccine.

Authors:  P Amoroso; C Izzo; R Smeraglia; G Lettieri; G Maio; G Flaminio; A Giorgio; P Fico; P Pierri; G Tarro
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

4.  Lack of antibodies to LAV/HTLV-III in hepatitis B vaccine recipients.

Authors:  G Papaevangelou; A Roumeliotou-Karayannis; G Kallinikos; K Politou
Journal:  Eur J Epidemiol       Date:  1985-12       Impact factor: 8.082

5.  Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection.

Authors:  R E Solomon; M VanRaden; R A Kaslow; D Lyter; B Visscher; H Farzadegan; J Phair
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

Review 6.  Traditional management of liver disorders.

Authors:  M Messner; P Brissot
Journal:  Drugs       Date:  1990       Impact factor: 9.546

7.  Hepatitis B: update on perinatal management. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1986-04-15       Impact factor: 8.262
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.